KYOTO PREFECTURAL UNIVERSITY OF MEDICINE

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: Private

Established: 1921-01-01

Employees: -

Market Cap: -

Website: http://www.f.kpu-m.ac.jp/j/english

Clinical Trials

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

Phase 3

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: Denosumab Injection

First Posted Date: 2017-10-30

Last Posted Date: 2023-10-06

Lead Sponsor: Kyoto Prefectural University of Medicine

Target Recruit Count: 160

Registration Number: NCT03324932

Locations: 🇯🇵
Hisako Ono, Kyoto, Japan

Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients

Not Applicable

Terminated

Conditions: Acute Myocardial Infarction
Angina Pectoris
Acute Coronary Syndrome
Hypertension
Myocardial Ischemia

Interventions: Drug: Micardis (Telmisartan)
Drug: Blopress (Candesartan)

First Posted Date: 2009-03-18

Last Posted Date: 2015-09-03

Lead Sponsor: Kyoto Prefectural University of Medicine

Target Recruit Count: 1500

Registration Number: NCT00863980

Locations: 🇯🇵
Akashi Municipal Hospital, Kobe, Japan
🇯🇵
Kouseikai Takeda Hospital, Kyoto, Japan
🇯🇵
Shakaihoken Kobe Central Hospital, Kobe, Japan

and more 29 locations

Pitavastatin on Carotid Intima-media Thickness

Not Applicable

Conditions: Hyperlipidemia
Carotid Artery Diseases

Interventions: Drug: Pitavastatin

First Posted Date: 2008-07-09

Last Posted Date: 2009-09-10

Lead Sponsor: Kyoto Prefectural University of Medicine

Target Recruit Count: 300

Registration Number: NCT00711919

Locations: 🇯🇵
Ayabe City Hospital, Ayabe, Kyoto, Japan
🇯🇵
Tanabe Central Hospital, Kyotanabe, Kyoto, Japan
🇯🇵
Maizuru Kyosai Hospital, Maizuru, Kyoto, Japan

and more 15 locations

Anti-Restenosis After AMI by Erythropoietin

Phase 4

Conditions: Acute Myocardial Infarction

First Posted Date: 2007-01-17

Last Posted Date: 2007-01-17

Lead Sponsor: Kyoto Prefectural University of Medicine

Target Recruit Count: 72

Registration Number: NCT00423020

Locations: 🇯🇵
Kyoto Prefectural University of Medicine, Kyoto, Japan

Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

Phase 4

Completed

Conditions: Hypertension
Ischemic Heart Disease
Congestive Heart Failure
Stroke

Interventions: Drug: Non-ARB
Drug: Valsartan

First Posted Date: 2005-09-08

Last Posted Date: 2012-12-12

Lead Sponsor: Kyoto Prefectural University of Medicine

Target Recruit Count: 3031

Registration Number: NCT00149227

Locations: 🇯🇵
Kyoto Prefectural University of Medicine, Kyoto, Japan

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy